Lacrimal gland pleomorphic adenoma: a narrative review
2022

Lacrimal Gland Pleomorphic Adenoma: A Review

Sample size: 57 publication Evidence: moderate

Author Information

Author(s): Lucas Horochoski, Guilherme Warmling Schulz, Andrei Koerbel

Primary Institution: Faculdade de Medicina, Universidade da Região de Joinville, Joinville, SC, Brazil

Hypothesis

What are the characteristics and treatment options for lacrimal gland pleomorphic adenoma?

Conclusion

Total excision of the tumor while preserving the pseudocapsule is the most effective treatment for lacrimal gland pleomorphic adenoma.

Supporting Evidence

  • Patients with LGPA typically present a slow-growing, painless mass.
  • Total tumor resection is the consensus for effective treatment.
  • Fine-needle aspiration biopsy can aid in diagnosis but may risk tumor recurrence.

Takeaway

This study looks at a type of tumor in the eye called pleomorphic adenoma, which usually grows slowly and is treated by removing it completely.

Methodology

The study reviewed 57 publications on lacrimal gland pleomorphic adenoma published since 2012.

Limitations

The review is limited to studies published in English, Spanish, or Portuguese and may not include all relevant literature.

Participant Demographics

Patients typically average 40 years old, with no significant predisposition based on race or geography.

Digital Object Identifier (DOI)

10.5935/0004-2749.2022-0057

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication